Aftermovie MS Hackathon
Afgelopen weekend mocht ik deel uitmaken van een uniek evenement. Verschillende expertises kwamen samen in Amsterdam! Met als uitkomst, vele mooie nieuw initiatieven.
Er waren 19 teams en prachtige ideen: -BigData -Sympthoon bestrijding -Quality of life solutions -Apps, wearables, etc.. The teams where from: UK, NL, Belgium.... Ik heb het als geweldig ervaren en dit is nu voor MS gedaan maar in algemeen moeten er meer van dit soort events gehouden worden. Het opend deuren, het versneld processen en brengt oplossingen.... MS Hackathon With the MS hackathon our intent is to show that collaborations between various disciplines and perspectives lead to concrete solutions, thus improving healthcare. With this hackathon the main focus is the chronic, yet unpredictable, disease of Multiple Sclerosis. Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. We need your help to beat MS! Multiple sclerosis (MS), also known as disseminated sclerosis or encephalomyelitis disseminata, is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a wide range of signs and symptoms. While the cause is not clear, the underlying mechanism is thought to be either destruction by the immune system or failure of the myelin-producing cells.MS is usually diagnosed based on the presenting signs and symptoms and the results of supporting medical tests. There is no known cure for multiple sclerosis. Treatments attempt to improve function after an attack and prevent new attacks. Medications used to treat MS, while modestly effective, can have adverse effects and be poorly tolerated. Many people pursue alternative treatments, despite a lack of evidence. Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. As of 2008, between 2 and 2.5 million people are affected globally with rates varying widely in different regions of the world and among different populations. In 2013, 20,000 people died worldwide from MS.